Navigation Links
Medbox Owned Vaporfection On Pace To Set Sales Record in 2013
Date:5/30/2013

HOLLYWOOD, Calif., May 30, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced today that Vaporfection, their wholly owned subsidiary, is on pace to post record sales in 2013 - surpassing last year's historic $1.4 million sales performance.

Vaporfection has a line of vaporizing products that are considered the highest quality in the world, with industry-leading features and user benefits, including:

  • Dual Method Delivery: The viVape™ vaporizer offers both bag and wand delivery methods in the same vaporizer, resulting in the quietest and fastest delivery in the industry.
  • Vapor Touch™: The viVape™ vaporizer features a user-friendly touchscreen control system and an incredibly fast startup time, as well as a glowing LED glass heating chamber to let you know you've reached your desired temperature.
  • Vapor Sense™ Temperature Control: The viVape™ is equipped with automatic temperature-sensing technology, featuring a digital microprocessor temperature controller directly wired to a thermo coupling temperature sensor.
  • Vapor Glass™: The viVape™ vaporizer is equipped with a patented Vapor Glass™ technology, featuring a laboratory-grade glass-on-glass heating element and chamber, which is designed to allow the heating source to be perfectly positioned for the most effective air/heat flow combination
  • Dual Current: The viVape™ vaporizer can be used in any country in the world; it's electrically compatible with 110/240 voltage for universal use.

"We are pleased with Vaporfection's sales to date, and we look forward to increasing sales exponentially when we gear up our new marketing campaign," stated Dr. Bruce Bedrick , CEO of Medbox, Inc. "As the medical marijuana industry continues to grow, patients are seeking better and healthier delivery systems. Vaporfection provides state-of-the-art technology in affordable and mass-marketable delivery products."

For more information on Medbox, visit: www.thedispensingsolution.com

For more information on Vaporfection, visit: www.vaporfection.com

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.


'/>"/>
SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox Comments on Federal Tolerance of State Marijuana Laws
2. AVTs Customer Medbox, Inc. Featured in Bloomberg Businessweek
3. Medboxs MedVend Automated Medication Dispensing System Now in Michigan
4. Medbox Completes Financial Audit
5. Medbox Featured in Fortune Magazine Cover Story
6. Medbox Acquires 50% of MedVend and its Patented Technologies
7. Medbox CEO Scheduled to Appear on Fox Business Channel
8. Medbox Signs Ad Deal With Entrepreneur Magazine
9. Medbox Featured in Huffington Post Report on the Legal Marijuana Industry
10. Medbox, Inc. Sees Opportunity in Several New States
11. Medbox, Inc. Comments on California Supreme Court Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
(Date:4/27/2017)... ... April 27, 2017 , ... The ... the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious ... Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney ...
(Date:4/27/2017)... ... ... Are you investing in the safety of your friends and family? Each ... While most of us assume this type of accident will never happen to us, ... taking the time to learn how to respond effectively or prevent these accidents from ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... to announce the ATA 2017 President’s Awards recipients, comprised of organizations and ... healthcare delivery. , The ATA 2017 President’s Awards recognize individuals and ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may ... pelvic conditions and has helped many women become pregnant upon treating their diagnosis. ... office-based and simple outpatient evaluations. We can provide the necessary information to ...
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
Breaking Medicine News(10 mins):